Talphera (TLPH) Return on Sales Growth (1y) (2012 - 2025)
Talphera (TLPH) Return on Sales Growth (1y) (2012 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 0.00 |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 0.00 |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 0.00 |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 0.00 |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 0.00 |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 0.00 |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 0.00 |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Talphera | 90.63 Mn | 90.63 Mn | - | -13,654.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 3.00 |
| Jun 30, 2025 | 3.00 |
| Mar 31, 2025 | 3.00 |
| Sep 30, 2024 | -1.00 |
| Jun 30, 2024 | 0.00 |
| Mar 31, 2024 | -16.00 |
| Dec 31, 2023 | 26.00 |
| Sep 30, 2023 | 24.00 |
| Jun 30, 2023 | 8.00 |
| Mar 31, 2023 | 26.00 |
| Dec 31, 2022 | 245.00 |
| Sep 30, 2022 | -18.00 |
| Jun 30, 2022 | 14.00 |
| Mar 31, 2022 | 10.00 |
| Dec 31, 2021 | -259.00 |
| Sep 30, 2021 | 2.00 |
| Jun 30, 2021 | -20.00 |
| Mar 31, 2021 | 24.00 |
| Dec 31, 2020 | 18.00 |
| Sep 30, 2020 | 14.00 |